Literature DB >> 34670863

Ecdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical Oncogenesis.

Sameer Mirza1, Achyuth Kalluchi1, Mohsin Raza1, Irfana Saleem2, Bhopal Mohapatra1, Dhananjaya Pal1, Michel M Ouellette2,3, Fang Qiu4,5, Lulu Yu6, Alexei Lobanov7, Zhi-Ming Zheng6, Ying Zhang8, Mansour A Alsaleem9,10, Emad A Rakha9, Hamid Band11,2,4,12,13, M Jordan Rowley11, Vimla Band11,2,4.   

Abstract

High-risk human papillomaviruses (HPV), exemplified by HPV16/18, are causally linked to human cancers of the anogenital tract, skin, and upper aerodigestive tract. Previously, we identified Ecdysoneless (ECD) protein, the human homolog of the Drosophila ecdysoneless gene, as a novel HPV16 E6-interacting protein. Here, we show that ECD, through its C-terminal region, selectively binds to high-risk but not to low-risk HPV E6 proteins. We demonstrate that ECD is overexpressed in cervical and head and neck squamous cell carcinoma (HNSCC) cell lines as well as in tumor tissues. Using The Cancer Genome Atlas dataset, we show that ECD mRNA overexpression predicts shorter survival in patients with cervical and HNSCC. We demonstrate that ECD knockdown in cervical cancer cell lines led to impaired oncogenic behavior, and ECD co-overexpression with E7 immortalized primary human keratinocytes. RNA-sequencing analyses of SiHa cells upon ECD knockdown showed to aberrations in E6/E7 RNA splicing, as well as RNA splicing of several HPV oncogenesis-linked cellular genes, including splicing of components of mRNA splicing machinery itself. Taken together, our results support a novel role of ECD in viral and cellular mRNA splicing to support HPV-driven oncogenesis. IMPLICATIONS: This study links ECD overexpression to poor prognosis and shorter survival in HNSCC and cervical cancers and identifies a critical role of ECD in cervical oncogenesis through regulation of viral and cellular mRNA splicing. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34670863      PMCID: PMC9138181          DOI: 10.1158/1541-7786.MCR-21-0567

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  59 in total

1.  rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data.

Authors:  Shihao Shen; Juw Won Park; Zhi-xiang Lu; Lan Lin; Michael D Henry; Ying Nian Wu; Qing Zhou; Yi Xing
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-05       Impact factor: 11.205

2.  Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.

Authors:  Manjie Xing; Wen Fong Ooi; Jing Tan; Aditi Qamra; Po-Hsien Lee; Zhimei Li; Chang Xu; Nisha Padmanabhan; Jing Quan Lim; Yu Amanda Guo; Xiaosai Yao; Mandoli Amit; Ley Moy Ng; Taotao Sheng; Jing Wang; Kie Kyon Huang; Chukwuemeka George Anene-Nzelu; Shamaine Wei Ting Ho; Mohana Ray; Lijia Ma; Gregorio Fazzi; Kevin Junliang Lim; Giovani Claresta Wijaya; Shenli Zhang; Tannistha Nandi; Tingdong Yan; Mei Mei Chang; Kakoli Das; Zul Fazreen Adam Isa; Jeanie Wu; Polly Suk Yean Poon; Yue Ning Lam; Joyce Suling Lin; Su Ting Tay; Ming Hui Lee; Angie Lay Keng Tan; Xuewen Ong; Kevin White; Steven George Rozen; Michael Beer; Roger Sik Yin Foo; Heike Irmgard Grabsch; Anders Jacobsen Skanderup; Shang Li; Bin Tean Teh; Patrick Tan
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis.

Authors:  Parama Dey; Satyanarayana Rachagani; Subhankar Chakraborty; Pankaj K Singh; Xiangshan Zhao; Channabasavaiah Basavaraju Gurumurthy; Judy M Anderson; Subodh Lele; Michael A Hollingsworth; Vimla Band; Surinder K Batra
Journal:  Clin Cancer Res       Date:  2012-09-12       Impact factor: 12.531

4.  Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.

Authors:  M A Dickson; W C Hahn; Y Ino; V Ronfard; J Y Wu; R A Weinberg; D N Louis; F P Li; J G Rheinwald
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells.

Authors:  Aditya Bele; Sameer Mirza; Ying Zhang; Riyaz Ahmad Mir; Simon Lin; Jun Hyun Kim; Channabasavaiah Basavaraju Gurumurthy; William West; Fang Qiu; Hamid Band; Vimla Band
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 7.  TSC2: filling the GAP in the mTOR signaling pathway.

Authors:  Yong Li; Michael N Corradetti; Ken Inoki; Kun-Liang Guan
Journal:  Trends Biochem Sci       Date:  2004-01       Impact factor: 13.807

8.  Downregulation of EIF4A2 in non-small-cell lung cancer associates with poor prognosis.

Authors:  Xi Shaoyan; Yong Juanjuan; Tao Yalan; He Ping; Liang Jianzhong; Wu Qinian
Journal:  Clin Lung Cancer       Date:  2013-07-16       Impact factor: 4.785

9.  Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression.

Authors:  Masahiko Ajiro; Rong Jia; Lifang Zhang; Xuefeng Liu; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

10.  ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation.

Authors:  Song-Hui Xu; Song Zhu; Yanjie Wang; Jin-Zhou Huang; Min Chen; Qing-Xia Wu; Yu-Tian He; Guang-Rong Yan
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more
  1 in total

1.  Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism.

Authors:  Bhopal C Mohapatra; Sameer Mirza; Aditya Bele; Channabasavaiah B Gurumurthy; Mohsin Raza; Irfana Saleem; Matthew D Storck; Aniruddha Sarkar; Sai Sundeep Kollala; Surendra K Shukla; Siddesh Southekal; Kay-Uwe Wagner; Fang Qiu; Subodh M Lele; Mansour A Alsaleem; Emad A Rakha; Chittibabu Guda; Pankaj K Singh; Robert D Cardiff; Hamid Band; Vimla Band
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.